Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Condition: Friedreich Ataxia Interventions: Biological: CTI-1601; Biological: Placebo Sponsor: Chondrial Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials